Cargando…

Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature

The relatively new discipline of pharmacovigilance (PV) aims to monitor the safety of drugs throughout their evolution and is essential to discovering new drug risks. Due to their specific and complex physiology, children, pregnant women, and elderly adults are more prone to adverse drug reactions (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanping, Wu, Yuanlin, Jiang, Tingting, Xing, Haiyan, Xu, Jing, Li, Chen, Ni, Rui, Zhang, Ni, Xiang, Guiyuan, Li, Li, Li, Ziwei, Gan, Lanlan, Liu, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540608/ https://www.ncbi.nlm.nih.gov/pubmed/37780667 http://dx.doi.org/10.1177/20420986231200746

Ejemplares similares

Cost-effectiveness of serplulimab as first-line therapy for extensive-stage small cell lung cancer in China
por: Xiang, Guiyuan, et al.
Publicado: (2023)

Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system
por: Jiang, Tingting, et al.
Publicado: (2022)

The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities
por: Chandler, Rebecca E.
Publicado: (2022)

Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies
por: Li, Yanping, et al.
Publicado: (2022)

Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities
por: Lewis, David John, et al.
Publicado: (2019)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions
por: Li, Yanping, et al.
Publicado: (2022)

The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic
por: Ogar, C., et al.
Publicado: (2020)

Challenges in pharmacovigilance
por: Dikshit, R. K.
Publicado: (2010)

Challenges and Opportunities in Aligning Conservation with Development in China’s National Parks: A Narrative Literature Review
por: Rule, Andrew, et al.
Publicado: (2022)

The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
por: Yue, Qun-Ying
Publicado: (2021)

Pharmacovigilance strategy: opportunities for cross-national learning
por: Fermont, Irene
Publicado: (2019)

Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and Considerations
por: Wong, Jenna, et al.
Publicado: (2022)

A narrative review of mechanisms of ferroptosis in cancer: new challenges and opportunities
por: Jiang, Mingyan, et al.
Publicado: (2021)

Opportunities and Challenges of Extracting Values in Autobiographical Narratives
por: Fischer, Ronald, et al.
Publicado: (2022)

Pharmacovigilance in China: Evolution and future challenges
por: Song, Haibo, et al.
Publicado: (2022)

Teaching Pharmacovigilance to Healthcare Students: Identifying Gaps and Opportunities for Improvement
por: Seselja Perisin, Ana, et al.
Publicado: (2021)

The MHRA pharmacovigilance inspection programme: priorities and challenges
por: Adams, Anna L, et al.
Publicado: (2019)

Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities
por: Kugener, Veronique F., et al.
Publicado: (2021)

Editorial for the Special Issue on Micro-Machining: Challenges and Opportunities
por: Luo, Xichun, et al.
Publicado: (2018)

Tobacco dependence treatment for special populations: challenges and opportunities
por: Castaldelli-Maia, João M., et al.
Publicado: (2020)

Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study
por: Waddingham, Ed, et al.
Publicado: (2022)

Computer Audition for Healthcare: Opportunities and Challenges
por: Qian, Kun, et al.
Publicado: (2020)

The Opportunities and Challenges of Digital Anatomy for Medical Sciences: Narrative Review
por: Wickramasinghe, Nilmini, et al.
Publicado: (2022)

The role of YWHAZ in cancer: A maze of opportunities and challenges
por: Gan, Yun, et al.
Publicado: (2020)

Challenges and opportunities in continuous flow processes for electrochemically mediated carbon capture
por: Liu, Yayuan, et al.
Publicado: (2022)

Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate
por: Chen, Xiaoyi, et al.
Publicado: (2018)

Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance
por: Matsuda, Shinichi, et al.
Publicado: (2017)

Special Issue on “The Application of Metabolomics in Clinical Practice: Challenges and Opportunities”
por: Mussap, Michele
Publicado: (2022)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Pancreatic cancer: challenges and opportunities
por: Zhu, Huiyun, et al.
Publicado: (2018)

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018)

Advances in the Development of Anti-Haemonchus contortus Vaccines: Challenges, Opportunities, and Perspectives
por: Ehsan, Muhammad, et al.
Publicado: (2020)

The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
por: Salas, Maribel, et al.
Publicado: (2023)

Recent Developments in Pharmacological Effect, Mechanism and Application Prospect of Diazeniumdiolates
por: Li, Bin, et al.
Publicado: (2020)

Editorial to the Special Issue “Food Bioactives: Chemical Challenges and Bio-Opportunities”
por: Pacifico, Severina, et al.
Publicado: (2021)

Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
por: Sahu, Ram Kumar, et al.
Publicado: (2014)

Challenges to the consolidation of pharmacovigilance practices in Brazil: limitations of the hospital pharmacist
por: Andrade, Paulo Henrique Santos, et al.
Publicado: (2020)

Harnessing the power of clinical decision support systems: challenges and opportunities
por: Chen, Zhao, et al.
Publicado: (2023)

21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pgqqtsvamsg5cp6e2uq91h9mbn